Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 8, 2004, Pages 1855-1858

  Wei, Zhi Liang ^a   Xiao, Yingxian ^b   Kellar, Kenneth J ^b   Kozikowski, Alan P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIBATIDINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANALGESIC ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NERVE CELL;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; LIGANDS; MOLECULAR STRUCTURE; NEURONS; NICOTINE; PYRIDINES; RATS; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1642603832     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.10.071     Document Type: Article

References (50)

1. Karlin A. Nat. Rev. Neurosci. 3:2002;102.
2. Holladay M.W., Dart M.J., Lynch J.K. J. Med. Chem. 40:1997;4169.
3. Lloyd G.K., Williams M. J. Pharmacol. Exp. Ther. 292:2000;461.
4. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van der Oost J., Smith A.B., Sixma T.K. Nature (London). 411:2001;269.
5. Novère N.L., Grutter T., Changeux J.-P. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3210.
6. Spande T.F., Garraffo H.M., Edwards M.W., Yeh H.J.C., Pannell L., Daly J.W. J. Am. Chem. Soc. 114:1992;3475.
7. Daly J.W. J. Nat. Prod. 61:1998;162.
8. Li T.C., Qian C.G., Eckman J., Huang D.F., Shen T.Y. Bioorg. Med. Chem. Lett. 3:1993;2759.
9. Qian C.G., Li T.C., Shen T.Y., Libertine-Garahan L., Eckman J., Biftu T., Ip S. Eur. J. Pharmacol. 250:1993;R13.
10. Fisher M., Huangfu D., Shen T.Y., Guyenet P.G. J. Pharmacol. Exp. Ther. 270:1994;702.
11. Badio B., Daly J.W. Mol. Pharm. 45:1994;563.
12. Liang F., Navarro H.A., Abraham P., Kotian P., Ding Y.-S., Fowler J., Volkow N., Kuhar M.J., Carroll F.I. J. Med. Chem. 40:1997;2293.
13. Otten A., Namyslo J.C., Stoermer M., Kaufmann D.E. Eur. J. Org. Chem. 1998;1997.
14. Seerden J.-P.G., Tulp M.Th.M., Scheeren H.W., Kruse C.G. Bioorg. Med. Chem. 6:1998;2103.
15. Spang J.E., Bertrand S., Westera G., Patt J.T., Schubiger P.A., Bertrand D. Chem. Biol. 7:2000;545.
16. Carroll F.I., Lee J.R., Navarro H.A., Brieaddy L.F., Abraham P., Damaj M.I., Martin B.R. J. Med. Chem. 44:2001;4039.
17. Che D., Wegge T., Stubbs M.T., Seitz G., Meier H., Methfessel C. J. Med. Chem. 44:2001;47.
18. Carroll F.I., Liang F., Navarro H.A., Brieaddy L.E., Abraham P., Damaj M.I., Martin B.R. J. Med. Chem. 44:2001;2229.
19. Carroll F.I., Lee J.R., Navarro H.A., Ma W., Brieaddy L.E., Abraham P., Damaj M.I., Martin B.R. J. Med. Chem. 45:2002;4755.
20. Kasyan A., Wagner C., Maier M.E. Tetrahedron. 54:1998;8047.
21. Malpass J.R., Cox C.D. Tetrahedron Lett. 40:1999;1419.
22. Cox C.D., Malpass J.R. Tetrahedron. 55:1999;11879.
23. Cox C.D., Malpass J.R., Gordon J., Rosen A. J. Chem. Soc., Perkin Trans 1. 2001;2372.
24. Bai D., Xu R., Chu G., Zhu X. J. Org. Chem. 61:1996;4600.
25. Malpass J.R., Hemmings D.A., Wallis A.L. Tetrahedron Lett. 37:1996;3911.
26. Wright E., Gallagher T., Sharples C.G.V., Wonnacott S. Bioorg. Med. Chem. Lett. 7:1997;2867.
27. Zhang C., Gyermek L., Trudell M.L. Tetrahedron Lett. 38:1997;5619.
28. Barlocco D., Cignarella G., Tondi D., Vianello P., Villa S., Bartolini A., Ghelardini C., Galeotti N., Anderson D.J., Kuntzweiler T.A., Colombo D., Toma L. J. Med. Chem. 41:1998;674.
29. Olivo H.F., Colby D.A., Hemenway M.S. J. Org. Chem. 64:1999;4966.
30. Malpass J.R., Hemmings D.A., Wallis A.L., Fletcher S.R., Patel S. J. Chem. Soc., Perkin Trans. 1. 2001;1044.
31. Rádl S., Hezký P., Hafner W., Budìší nský M., Hejnová L. Bioorg. Med. Chem. Lett. 10:2000;55.
32. Sharples C.G.V., Karig G., Simpson G.L., Spencer J.A., Wright E., Millar N.S., Wonnacott S., Gallagher T. J. Med. Chem. 45:2002;3235.
33. Gohlke H., Gündisch D., Schwarz S., Seitz G., Tilotta M.C., Wegge T. J. Med. Chem. 45:2002;1064.
34. Wei Z.-L., George C., Kozikowski A.P. Tetrahedron Lett. 44:2003;3847.
35. Wei Z.-L., Xiao Y., George C., Kellar K.J., Kozikowski A.P. Org. Biomol. Chem. 1:2003;3878.
36. Wei Z.-L., Petukhov P.A., Xiao Y., Tückmantel W., George C., Kellar K.J., Kozikowski A.P. J. Med. Chem. 46:2003;921.
37. Abe H., Arai Y., Aoyagi S., Kibayashi C. Tetrahedron Lett. 44:2003;2971.
38. Brieaddy L.E., Mascarella S.W., Navarro H.A., Atkinson R.N., Damaj M.I., Martin B.R., Carroll F.I. Tetrahedron Lett. 42:2001;3795.
39. Horti A.G., Scheffel U., Kimes A.S., Musachio J.L., Ravert H.T., Mathews W.B., Zhan Y., Finley P.A., London E.D., Dannals R.F. J. Med. Chem. 41:1998;4199.
40. Glennon R.A., Herndon J.L., Dukat M. Med. Chem. Res. 4:1994;461.
41. Gohlke H., Schwarz S., Gündisch D., Tilotta M.C., Weber A., Wegge T., Seitz G. J. Med. Chem. 46:2003;2031.
42. Villarroya M., Grandía L., López M.G., García A.G., Cueto S., García-Navio J.-L., Alvarez-Builla J. Bioorg. Med. Chem. 4:1996;1177.
43. Boido C.C., Tasso B., Boido V., Sparatore F. Farmaco. 58:2003;265.
44. Nicolotti O., Boido C.C., Sparatore F., Carotti A. Farmaco. 57:2002;469.
45. Boido C.C., Sparatore F. Farmaco. 54:1999;438.
46. Cheng J., Moore Z., Stevens E.D., Trudell M.L. J. Org. Chem. 67:2002;5433.
47. Magidson O., Menschikoff G. Chem. Ber. 58:1925;113.
48. Hama Y., Nobuhara Y., Aso Y., Otsubo T., Ogura F. Bull. Chem. Soc. Jpn. 61:1988;1683.
49. As the epibatidine used as intermediate is racemic, compounds 6a-d are mixtures of DL and meso diastereoisomers, as shown in the NMR spectra.
50. Meyer E.L., Xiao Y., Kellar K.J. Mol. Pharmacol. 60:2001;568.